Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Jun;63(6):986–992. doi: 10.1038/bjc.1991.215

Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival.

M Wolf 1, R Holle 1, K Hans 1, P Drings 1, K Havemann 1
PMCID: PMC1972562  PMID: 1648949

Abstract

The data of 766 patients participating in three German multicentre trials were analysed with regard to the relationship between baseline characteristics and prognosis in small cell lung cancer (SCLC). The central aim of this analysis has been to evaluate the role of gender as an independent prognostic factor in SCLC. The minimum follow-up period for the 652 male and 114 female patients was 36 months. Female patients were shown to have a higher complete remission rate (35% vs 25%), a superior median survival (ms) (12.1 months (mo) vs 9.8 mo), and a favourable 2-year survival rate (2ys) (19% vs 8%) to male ones. Various other prognostic factors have been proved to be significant, such as extent of disease, clinical performance status, and history of smoking, whereas weight loss prior to chemotherapy and age have been less important factors. We have been able to ascertain that women's responses were better than those of male patients independent of any other relevant prognostic variable. Furthermore, results were found to be even more advantageous for female patients with additional favourable prognostic parameters, i.e. for patients with limited disease (ms 15.2 mo vs 12.0 mo; 2ys 29% vs 9%) or with good performance status (ms 13.4 mo vs 10.4 mo; 2ys 24% vs 7%). A most remarkable observation was made in that the favourable prognostic effect of the female gender was restricted to patients aged less than 60 years (ms 13.3 mo vs 10.1 mo; 2ys 26% vs 5%), whereas for older women no advantages over men's results were established (ms 9.3 ml vs 9.1 mo; 2ys 8% vs 7%). A proportion of 32% of female patients with limited disease aged less than 60 years achieved a 3-year survival rate. We conclude (a) that sex constitutes a major prognostic factor in SCLC and is especially useful as a predictor for long-term survival, and (b) that the favourable prognostic value of the female sex is restricted to younger patients.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Einhorn L. H., Bond W. H., Hornback N., Joe B. T. Long-term results in combined-modality treatment of small cell carcinoma of the lung. Semin Oncol. 1978 Sep;5(3):309–313. [PubMed] [Google Scholar]
  2. Havemann K., Wolf M., Holle R., Gropp C., Drings P., Manke H. G., Hans K., Schroeder M., Heim M., Victor N. Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial. Cancer. 1987 Mar 15;59(6):1072–1082. doi: 10.1002/1097-0142(19870315)59:6<1072::aid-cncr2820590605>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  3. Ihde D. C., Makuch R. W., Carney D. N., Bunn P. A., Cohen M. H., Matthews M. J., Minna J. D. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis. 1981 May;123(5):500–507. doi: 10.1164/arrd.1981.123.5.500. [DOI] [PubMed] [Google Scholar]
  4. Livingston R. B., Moore T. N., Heilbrun L., Bottomley R., Lehane D., Rivkin S. E., Thigpen T. Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study. Ann Intern Med. 1978 Feb;88(2):194–199. doi: 10.7326/0003-4819-88-2-194. [DOI] [PubMed] [Google Scholar]
  5. Maasberg M., Rotsch M., Jaques G., Enderle-Schmidt U., Weehle R., Havemann K. Androgen receptors, androgen-dependent proliferation, and 5 alpha-reductase activity of small-cell lung cancer cell lines. Int J Cancer. 1989 Apr 15;43(4):685–691. doi: 10.1002/ijc.2910430424. [DOI] [PubMed] [Google Scholar]
  6. Maurer L. H., Pajak T. F. Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study. Cancer Treat Rep. 1981 Sep-Oct;65(9-10):767–774. [PubMed] [Google Scholar]
  7. Morstyn G., Ihde D. C., Lichter A. S., Bunn P. A., Carney D. N., Glatstein E., Minna J. D. Small cell lung cancer 1973-1983: early progress and recent obstacles. Int J Radiat Oncol Biol Phys. 1984 Apr;10(4):515–539. doi: 10.1016/0360-3016(84)90032-4. [DOI] [PubMed] [Google Scholar]
  8. Osterlind K., Hansen H. H., Hansen M., Dombernowsky P., Andersen P. K. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol. 1986 Sep;4(9):1307–1313. doi: 10.1200/JCO.1986.4.9.1307. [DOI] [PubMed] [Google Scholar]
  9. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rawson N. S., Peto J. An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. Br J Cancer. 1990 Apr;61(4):597–604. doi: 10.1038/bjc.1990.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Souhami R. L., Bradbury I., Geddes D. M., Spiro S. G., Harper P. G., Tobias J. S. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res. 1985 Jun;45(6):2878–2882. [PubMed] [Google Scholar]
  12. Souhami R. L., Law K. Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research. Br J Cancer. 1990 Apr;61(4):584–589. doi: 10.1038/bjc.1990.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Spiegelman D., Maurer L. H., Ware J. H., Perry M. C., Chahinian A. P., Comis R., Eaton W., Zimmer B., Green M. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients. J Clin Oncol. 1989 Mar;7(3):344–354. doi: 10.1200/JCO.1989.7.3.344. [DOI] [PubMed] [Google Scholar]
  14. Vincent M. D., Ashley S. E., Smith I. E. Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1589–1599. doi: 10.1016/0277-5379(87)90436-6. [DOI] [PubMed] [Google Scholar]
  15. Vogelsang G. B., Abeloff M. D., Ettinger D. S., Booker S. V. Long-term survivors of small cell carcinoma of the lung. Am J Med. 1985 Jul;79(1):49–56. doi: 10.1016/0002-9343(85)90545-5. [DOI] [PubMed] [Google Scholar]
  16. Wolf M., Havemann K., Holle R., Gropp C., Drings P., Hans K., Schroeder M., Heim M., Dommes M., Mende S. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial. J Clin Oncol. 1987 Dec;5(12):1880–1889. doi: 10.1200/JCO.1987.5.12.1880. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES